EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Medicinal Plants for Major Depressive Disorder

Amanda Gollo Bertollo iD, Luiza Spohr, Ana Élica Bearzi, Kelli Maria Kreuz, Zuleide Maria Ignácio iD

Brain Sciences · 13.02.2026 · 16 (2) · 223

DOI: 10.3390/brainsci16020223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 13.02.2026. Verfasst von Amanda Gollo Bertollo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Neurosciences, Federal University of Santa Catarina, Florianópolis 88035-972, SC, Brazil. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina - FAPESC, Universidade Federal da Fronteira Sul - UFFS, FAPESC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major Depressive Disorder (MDD) is a severe, chronic illness for which conventional treatments often show limited efficacy and side effects, driving a renewed interest in traditional medicinal plants. The therapeutic promise of these plants lies in their multi-targeted action, influencing neurotransmitter systems, modulating neuroinflammation and oxidative stress, impacting neuroplasticity, and regulating the Hypothalamic–Pituitary–Adrenal (HPA) axis. Despite their clinical potential, the use of medicinal plants is associated with challenges, including complex pharmacokinetics, significant adverse effects, and the risk of herb–drug interactions, alongside concerns regarding standardization and quality control. This manuscript aims to examine the therapeutic potential of key medicinal plants for managing MDD, including Hypericum perforatum, Rhodiola rosea, Melissa officinalis, Passiflora incarnata, Valeriana officinalis, and Cannabis sativa. Additionally, the review addresses emerging candidates such as Curcuma longa, Withania somnifera, Panax ginseng and Centella asiatica. By focusing on their mechanisms of action, pharmacokinetics, and associated risks, this review provides a more comprehensive understanding of their role in modern psychiatric care.

Schlagwörter

Stichwörter der Autor:innen

HPA axismajor depressive disordermedicinal plantsneuroinflammationneuroplasticityneurotransmitters

Autor:innen und Institutionen

  • Graduate Program in Neurosciences, Federal University of Santa Catarina, Florianópolis 88035-972, SC, Brazil.
  • Graduate Program in Biomedical Sciences, Laboratory of Physiology, Pharmacology, and Psychopathology, Federal University of Fronteira Sul, Chapecó 89815-899, SC, Brazil.

ORCID-Profile: Amanda Gollo Bertollo, Zuleide Maria Ignácio

Förderung

  • Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina - FAPESC
  • Universidade Federal da Fronteira Sul - UFFS
  • FAPESC
  • UFFS

Zitieren

APA

Bertollo, A. G., Spohr, L., Bearzi, A. É., Kreuz, K. M., & Ignácio, Z. M. (2026). Medicinal Plants for Major Depressive Disorder. Brain Sciences, 16(2), 223. https://doi.org/10.3390/brainsci16020223

Vancouver

Bertollo AG, Spohr L, Bearzi AÉ, Kreuz KM, Ignácio ZM. Medicinal Plants for Major Depressive Disorder. Brain Sciences. 2026;16(2):223. doi:10.3390/brainsci16020223

BibTeX
@article{Bertollo2026,
  author = {Bertollo, Amanda Gollo and Spohr, Luiza and Bearzi, Ana Élica and Kreuz, Kelli Maria and Ignácio, Zuleide Maria},
  title = {Medicinal Plants for Major Depressive Disorder},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {223},
  doi = {10.3390/brainsci16020223}
}
Kostenlos starten →